金陵药业(000919.SZ)：上半年净利润4833.35万元 同比下降14.08%

Group 1 - The core viewpoint of the article is that Jinling Pharmaceutical (000919.SZ) reported a decline in both revenue and net profit for the first half of 2025 compared to the same period last year [1] Group 2 - The company achieved operating revenue of 1.601 billion yuan, representing a year-on-year decrease of 6.62% [1] - The net profit attributable to shareholders of the listed company was 48.33 million yuan, down 14.08% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 35.51 million yuan, reflecting a year-on-year decline of 21.55% [1] - The basic earnings per share were reported at 0.0777 yuan [1]